 Foramen Ovale, Patent
"Foramen Ovale, Patent" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A condition in which the FORAMEN OVALE in the ATRIAL SEPTUM fails to close shortly after birth. This results in abnormal communications between the two upper chambers of the heart. An isolated patent ovale foramen without other structural heart defects is usually of no hemodynamic significance.
| Descriptor ID |
D054092
|
| MeSH Number(s) |
C14.240.400.560.375.258 C14.280.400.560.375.258 C16.131.240.400.560.375.258
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Foramen Ovale, Patent".
- Diseases [C]
- Cardiovascular Diseases [C14]
- Cardiovascular Abnormalities [C14.240]
- Heart Defects, Congenital [C14.240.400]
- Heart Septal Defects [C14.240.400.560]
- Heart Septal Defects, Atrial [C14.240.400.560.375]
- Foramen Ovale, Patent [C14.240.400.560.375.258]
- Heart Diseases [C14.280]
- Heart Defects, Congenital [C14.280.400]
- Heart Septal Defects [C14.280.400.560]
- Heart Septal Defects, Atrial [C14.280.400.560.375]
- Foramen Ovale, Patent [C14.280.400.560.375.258]
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]
- Congenital Abnormalities [C16.131]
- Cardiovascular Abnormalities [C16.131.240]
- Heart Defects, Congenital [C16.131.240.400]
- Heart Septal Defects [C16.131.240.400.560]
- Heart Septal Defects, Atrial [C16.131.240.400.560.375]
- Foramen Ovale, Patent [C16.131.240.400.560.375.258]
Below are MeSH descriptors whose meaning is more specific than "Foramen Ovale, Patent".
This graph shows the total number of publications written about "Foramen Ovale, Patent" by people in this website by year, and whether "Foramen Ovale, Patent" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2007 | 1 | 0 | 1 | | 2008 | 4 | 0 | 4 | | 2009 | 2 | 0 | 2 | | 2012 | 2 | 0 | 2 | | 2013 | 6 | 0 | 6 | | 2014 | 3 | 0 | 3 | | 2015 | 1 | 0 | 1 | | 2016 | 1 | 0 | 1 | | 2017 | 1 | 0 | 1 | | 2018 | 5 | 0 | 5 | | 2019 | 2 | 0 | 2 | | 2020 | 5 | 1 | 6 | | 2021 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Foramen Ovale, Patent" by people in Profiles.
-
Pristipino C, Germonpré P, Toni D, Sievert H, Meier B, D'Ascenzo F, Berti S, Onorato EM, Bedogni F, Mas JL, Scacciatella P, Hildick-Smith D, Gaita F, Kyrle PA, Thomson J, Derumeaux G, Sibbing D, Chessa M, Hornung M, Zamorano J, Dudek D, D'Ascenzo F, Omedè P, Ballocca F, Barbero U, Giordana F, Gili S, Iannaccone M, Akagi T, Anzola G, Carroll J, Dalvi B, Angelis C, Junbo G, Kasner SE, Michel-Behnke I, Musumeci G, Søndergaard L, Tarantini G, Biondi-Zoccai GGL, Capodanno D, Valgimigli M, Byrne R, Kunadian V. European position paper on the management of patients with patent foramen ovale. Part II - Decompression sickness, migraine, arterial deoxygenation syndromes and select high-risk clinical conditions. Eur Heart J. 2021 04 21; 42(16):1545-1553.
-
Kent DM, Saver JL, Ruthazer R, Furlan AJ, Reisman M, Carroll JD, Smalling RW, Jüni P, Mattle HP, Meier B, Thaler DE. Risk of Paradoxical Embolism (RoPE)-Estimated Attributable Fraction Correlates With the Benefit of Patent Foramen Ovale Closure: An Analysis of 3 Trials. Stroke. 2020 10; 51(10):3119-3123.
-
Burkett DA. Common Left-to-Right Shunts. Pediatr Clin North Am. 2020 10; 67(5):821-842.
-
Shah AH, Kass M, Carroll J. Is Hypoxia in Standing Position Mandatory in Defining Platypnea-Orthodeoxia Syndrome? JACC Cardiovasc Interv. 2020 09 28; 13(18):e165-e166.
-
Elgendy AY, Saver JL, Amin Z, Boudoulas KD, Carroll JD, Elgendy IY, Grunwald IQ, Gertz ZM, Hijazi ZM, Horlick EM, Kasner SE, Kent DM, Kumar P, Kavinsky CJ, Liebeskind DS, Lutsep H, Mojadidi MK, Messé SR, Mas JL, Mattle HP, Meier B, Mahmoud A, Mahmoud AN, Nietlispach F, Patel NK, Rhodes JF, Reisman M, Sommer RJ, Sievert H, Søndergaard L, Zaman MO, Thaler D, Tobis JM. Proposal for Updated Nomenclature and Classification of Potential Causative Mechanism in Patent Foramen Ovale-Associated Stroke. JAMA Neurol. 2020 07 01; 77(7):878-886.
-
Messé SR, Gronseth GS, Kent DM, Kizer JR, Homma S, Rosterman L, Carroll JD, Ishida K, Sangha N, Kasner SE. Practice advisory update summary: Patent foramen ovale and secondary stroke prevention: Report of the Guideline Subcommittee of the American Academy of Neurology. Neurology. 2020 05 19; 94(20):876-885.
-
Won H, Carroll JD. Comparative effectiveness research applied to medical devices: Which PFO closure device is the best? Catheter Cardiovasc Interv. 2020 02 15; 95(3):373-374.
-
Carroll AM, Carroll JD. Device Closure of Patent Foramen Ovale for Cryptogenic Stroke: Patient Selection and Outcomes According to New Randomized Trials. Curr Cardiol Rep. 2019 04 22; 21(6):48.
-
Horlick E, Kavinsky CJ, Amin Z, Boudoulas KD, Carroll JD, Hijazi ZM, Leifer D, Lutsep HL, Rhodes JF, Tobis JM. SCAI expert consensus statement on operator and institutional requirements for PFO closure for secondary prevention of paradoxical embolic stroke: The American Academy of Neurology affirms the value of this statement as an educational tool for neurologists. Catheter Cardiovasc Interv. 2019 04 01; 93(5):859-874.
-
Kasner SE, Swaminathan B, Lavados P, Sharma M, Muir K, Veltkamp R, Ameriso SF, Endres M, Lutsep H, Messé SR, Spence JD, Nedeltechev K, Perera K, Santo G, Olavarria V, Lindgren A, Bangdiwala S, Shoamanesh A, Berkowitz SD, Mundl H, Connolly SJ, Hart RG. Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial. Lancet Neurol. 2018 12; 17(12):1053-1060.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|